Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients (NCT06468618)
🩺 Plain-English Summary (8th-Grade Level)
Pediatric patients undergoing stem cell transplant (SCT) are hospitalized for extended periods and are at high risk for sleep disturbances. In order to begin to address the environmental issues that SCT recipients face during inpatient hospitalizations, investigators will conduct a single arm pilot study of a program entitled 'Developing Restful Environments and Management Strategies' (DREAMS). The program will provide children receiving SCT and families with information and a kit that includes tools which may support sleep and circadian health during an inpatient hospitalization.
Who can join: Review the eligibility criteria below.
Location: Boston Children's Hospital — Boston, Massachusetts
Age range: 9 Years to 17 Years
🧪 Interventions in This Study
- DREAMS Program Video and Care Kit (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Boston Children's Hospital — Boston, Massachusetts
- Dana-Farber Cancer Institute — Boston, Massachusetts
📞 Contact the Study Coordinator
Phone: (617) 632-6221
Email: lucille_lokko@dfci.harvard.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Stem Cell Transplant Complications
- Multidisciplinary Intervention In Chronic GVHD — Boston, Massachusetts
- Delirium in Children Undergoing Stem Cell Transplantation — San Francisco, California
- Intestinal Microbiota in Stem Cell Transplant Transplant Admission — Detroit, Michigan
- Loratadine for the Prevention of G-CSF-related Bone Pain — Edmonton, Alberta
- IS-free Treg HaploHCT — Boston, Massachusetts
Explore by condition: All Stem Cell Transplant Complications clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.